Price · last 3 months · daily close
PSX price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Energy
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Price · last 3 months · daily close
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
Value Scorecard · run 2026-10-18
Earnings & returns
Diluted EPS: $23.27 (2022), $15.48 (2023), $4.99 (2024), $10.79 (2025). The latest figure is half the 2022 figure or less; the framework scores that as 1.
ROE (net income / common equity): 37.3% (2022), 22.9% (2023), 7.7% (2024), 15.1% (2025). Median 19.0%, lowest 7.7%; the framework scores a median 15-20% as 4.
ROIC of -9.8%: earnings before interest and taxes of -$4.41B (pre-tax income -$4.96B plus interest expense $550.00M; the 10-K's financial data has no standard operating income figure) divided by $45.20B of capital (total assets $54.72B minus current liabilities $9.52B), fiscal year to Dec 31, 2020, as filed in the 10-K (SEC EDGAR). The framework scores below 5% as 1.
Net margin of 4.7%; the framework scores 0-5% as 2; gross margin 13.1%, operating margin 8.5%.
Balance sheet & cash
Debt-to-equity of 0.63; the framework scores 0.3-0.8 as 4 (total debt $20.57B, total cash $4.10B).
Free cash flow (operating cash flow minus capital expenditure): $8.93B (2022), $4.87B (2023), $2.33B (2024), $2.73B (2025). The latest figure is half the 2022 figure or less; the framework scores that as 1.
Retained earnings, as filed in the 10-Ks (SEC EDGAR): $25.43B (2022), $30.55B (2023), $30.77B (2024), $33.24B (2025). It rose every year; the framework scores that as 5.
Valuation models
IV = EPS x (8.5 + 2g) x (4.4 / Y) = $17.50 x (8.5 + 2 x 0.0) x (4.4 / 4.5) = $145.44 (EPS CAGR -16.5% floored at 0%; the formula returns a negative value below -4.25% growth). Current price $293.17; price is 101.6% above the model value.
FCF/share = $11.391, stage 1 growth = 0.0% (revenue CAGR -5.2% floored at 0%; the company is valued as if it does not grow rather than extrapolating the decline) for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $43.18, PV of terminal value = $104.08, DCF value = $147.26. Current price $293.17; price is 99.1% above the model value.
Graham value $145.44 (price is 101.6% above the model value); DCF value $147.26 (price is 99.1% above the model value).
P/B of 3.71; the framework scores 3.0-5.0 as 2.
Business quality
A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Above 15% in 6 of 10 years (2011-2020); lowest -9.8%, highest 21.3%.
Gross margin, each year
Between 8.4% and 25.9% over 10 years (a range of 17.5 points).
Competition, in the company’s own words · 10-K filed Feb 20, 2026
Our businesses operate in a competitive environment. Elements of competition for each of our Chemicals, Refining and Renewable Fuels segments include product improvement, new product development, low-cost structures, ability to source and run adequate and high-quality feedstocks, and efficient manufacturing and distribution systems. In the M&S segment, competitive factors include product properties, reliability of supply, customer service, price and credit terms, advertising and sales promotion, and development of customer loyalty to branded products. In the Midstream segment, our crude oil and refined petroleum products pipelines face competition related primarily to quality of customer service and reliability, competitive rates. the proximity of assets to customers and market hubs. In addition, the Midstream segment competes to deliver natural gas and NGL to customers. Principal methods of competing include economically securing the right to purchase raw natural gas for gathering systems, managing the pressure of those systems, operating efficient NGL and gas processing plants and securing placement for the products produced.
The opening of the company’s “COMPETITION” section in its 10-K, quoted word for word, not summarized or edited. It is the company’s own description, not Valerius’s view, and may include the company’s expectations. Open the filing.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. For a year whose 10-K financial data has no standard operating income figure, earnings before interest and taxes (pre-tax income plus interest expense) is used. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $17.66B paid out against $18.86B of free cash flow (pass); total debt $17.19B to $19.72B, up 14.7%, 2.0x EBITDA (fail: up more than 10% and above 2x EBITDA); shares outstanding 0.47B to 0.40B, down 13.9% (pass). 3 of 4 tests passed; the framework scores that as 4.
Filings
Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $17.50, g = 0.0%, Y = 4.5
g floored at 0.0% (3-year EPS CAGR was -16.5%; below -4.25% the formula returns a negative value)
IV = $145.44
Current price $293.17 vs Graham value $145.44 — price is 101.6% above the model value.
DCF:
FCF/share = $11.391
Stage 1 growth = 0.0% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Stage 1 g floored at 0.0% (3-year revenue CAGR was -5.2%; the company is valued as if it does not grow rather than extrapolating the decline)
Y1: $11.391 → PV $10.356
Y2: $11.391 → PV $9.414
Y3: $11.391 → PV $8.558
Y4: $11.391 → PV $7.780
Y5: $11.391 → PV $7.073
Stage 1 PV sum = $43.18
Terminal value at end of Y5 = $167.62
PV of terminal value = $104.08
DCF value = $147.26
Current price $293.17 vs DCF value $147.26 — price is 99.1% above the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $293.17. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.